A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9

Abstract. Background:. The new emerging avian influenza A H7N9 virus, causing severe human infection with a mortality rate of around 41%. This study aims to provide a novel treatment option for the prevention and control of H7N9. Methods:. H7 hemagglutinin (HA)-specific B cells were isolated from pe...

Full description

Bibliographic Details
Main Authors: Jingxin Li, Li Zhang, Linlin Bao, Yuxiao Wang, Lin Qiu, Jialei Hu, Rong Tang, Huiyan Yu, Jun Shan, Yan Li, Chuan Qin, Fengcai Zhu, Jing Ni
Format: Article
Language:English
Published: Wolters Kluwer 2022-04-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000002001